KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $215.2 million.

  • Hologic's Free Cash Flow rose 2475.36% to $215.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year decrease of 1237.37%. This contributed to the annual value of $998.3 million for FY2025, which is 1768.63% down from last year.
  • Per Hologic's latest filing, its Free Cash Flow stood at $215.2 million for Q4 2025, which was up 2475.36% from $341.4 million recorded in Q3 2025.
  • Hologic's Free Cash Flow's 5-year high stood at $1.0 billion during Q1 2022, with a 5-year trough of $148.8 million in Q3 2022.
  • In the last 5 years, Hologic's Free Cash Flow had a median value of $313.9 million in 2022 and averaged $351.8 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 42442.21% in 2021, then plummeted by 8207.53% in 2023.
  • Quarter analysis of 5 years shows Hologic's Free Cash Flow stood at $543.7 million in 2021, then crashed by 56.3% to $237.6 million in 2022, then decreased by 16.96% to $197.3 million in 2023, then decreased by 12.57% to $172.5 million in 2024, then rose by 24.75% to $215.2 million in 2025.
  • Its Free Cash Flow was $215.2 million in Q4 2025, compared to $341.4 million in Q3 2025 and $330.5 million in Q2 2025.